Namal Nawana is a business leader and healthcare entrepreneur with a particular focus in the medical devices and diagnostics industry. Mr Nawana is founder of Sapphiros and since August 2025, Worldwide President of DePuy Synthesis.
Mr Nawana has extensive experience leading global public companies and was formerly Chief Executive Officer and a member of the Board of Directors of Smith & Nephew Plc, based in the United Kingdom and Chief Executive Officer and member of the Board of Directors of Alere Inc, a NYSE listed company, until its $8 billion acquisition by Abbott Laboratories in 2017. Before joining Alere, he spent more than 15 years at Johnson & Johnson in progressively senior leadership roles globally, including the role of Worldwide President of Johnson & Johnson’s multibillion dollar DePuy-Synthes Spine business.
Mr Nawana was a member of the Board of Directors of Hologic, Inc. a Nasdaq listed company and past board member of Advamed and Advamed -Dx the peak industry associations of the Medical Device and Diagnostics industries. Mr Nawana is the Founder of Neoenta, a private venture capital company focused in health care. He is also a co-founder in multiple medical device and in vitro diagnostics companies.
Mr. Nawana holds an undergraduate degree in Mechanical Engineering and a Master’s degree in Medical Science from the University of Adelaide, South Australia, as well as an MBA from Henley Management College.
